For all media enquiries please contact Jennifer Durante, Head of Communications & Fundraising Email media@melanoma.org.au Phone 0412 798 990.
Australian researchers launch world-first tool to predict patient response to immunotherapy
New clinical tool developed by Melanoma Institute Australia hailed a breakthrough in personalising treatment for all cancer patients.
Skin Cancer Tasmania merges with Melanoma Institute Australia
Tasmanian skin cancer patients to benefit from increased prevention and awareness campaigns, and bolstered melanoma support services.
MIA researchers showcase new frontier in melanoma treatment at ASCO 2022
An unprecedented number of breakthroughs to be presented by MIA researchers at world's leading clinical oncology conference.
Thank you to everyone involved in Melanoma March 2022
A message of thanks from Matthew Browne, Melanoma Institute Australia CEO, to everyone involved in Melanoma March. Funds raised allow our Personalised Immunotherapy Platform (PIP) Clinical Trial to commence.
A melanoma message from NRL legend Ray Price and his wife Sandy
The pair, who have both been diagnosed with melanoma, are keen to raise funds and awareness for melanoma and will be participating in Melanoma March Coolangatta.
Global breakthrough in stopping melanoma spreading around body
Immunotherapy after surgery proven effective in reducing disease spread in high risk early stage patients.
A heartwarming return to Melanoma March events
Spirits were high as everyone enjoyed the return of physical Melanoma March events, and 'March Your Way' initiatives!
MIA Co-Medical Directors join Riverina Melanoma Ride
Prof Georgina Long and Prof Richard Scolyer, cycled from Albury to Wagga on Day 1 of Riverina Melanoma Ride.
Research predicts global melanoma rate to increase by 50% by 2040
New research, co-authored by MIA's Prof Anne Cust, published in the journal JAMA Dermatology.
Federal Budget omission a missed opportunity to save lives from melanoma
Urgent long-term funding needed to modernise the ‘Slip Slop Slap’ campaign.
FDA approves new combination immunotherapy
Australian researchers and patients were critical to trialling this breakthrough new treatment for advanced melanoma patients.
Two Melanoma March events postponed
Due to flooding, Melanoma March events in Western Sydney and Brisbane are postponed to May.
Jane Varley says:
Kerry Bray says:
MIA says: